Company BioLineRx Ltd.

Equities

BLRX

IL0011015182

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for BioLineRx Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:13 2024-06-10 am EDT			5-day change	1st Jan Change
17.2 ^ILa	+0.58%		-3.91%	-54.97%

May. 30	BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease	CI
May. 28	Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Number of employees: 79

ILS in Million	2022	Weight	2023	Weight	Delta
License 96.0 %	-	-	17	96.0 %	-
Oncology and Hematology 4.0 %	0	nan %	1	4.0 %	-

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	0	nan %	18	100.0 %	-

Managers	Title	Age	Since
Philip Serlin CEO	Chief Executive Officer	63	09-05-23
Mali Zeevi DFI	Director of Finance/CFO	48	08-12-31
Irit Gliko-Kabir CTO	Chief Tech/Sci/R&D Officer	-	17-08-31
John Lacey IRC	Investor Relations Contact	-	-
Asaf Aloni PRN	Corporate Officer/Principal	-	-
Tali Yaron Dalah AUD	Comptroller/Controller/Auditor	46	-
Ella Sorani PRN	Corporate Officer/Principal	56	17-01-31
Holly May PRN	Corporate Officer/Principal	-	22-06-15
Tsipi Keren-Lehrer PRN	Corporate Officer/Principal	-	19-07-31

Members of the board	Title	Age	Since
Sandra Panem BRD	Director/Board Member	77	14-02-23
Avraham Molcho BRD	Director/Board Member	66	09-12-31
Aharon Schwartz CHM	Chairman	80	03-12-31
Barbara-Jean Bormann-Kennedy BRD	Director/Board Member	65	13-08-18
Raf Hofstein BRD	Director/Board Member	74	02-12-31
Rami Dar BRD	Director/Board Member	67	22-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,086,589,165	1,086,589,164 ( 100.00 %)	0	100.00 %

Name	Equities	%	Valuation
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 8.543 %	102,437,055	8.543 %	5 M ILa
Aharon Schwartz 0.3090 %	3,705,000	0.3090 %	179 989 ILa
KSM Mutual Funds Ltd. 0.2153 %	2,581,544	0.2153 %	125 411 ILa
Migdal Mutual Funds Ltd. 0.1115 %	1,337,063	0.1115 %	64 955 ILa
Mali Zeevi 0.0274 %	328,665	0.0274 %	15 967 ILa
Dimensional Fund Advisors Ltd. 0.0255 %	305,918	0.0255 %	14 861 ILa
Philip Serlin 0.0143 %	171,900	0.0143 %	8 351 ILa
Ayalon Mutual Funds Ltd. 0.0122 %	146,813	0.0122 %	7 132 ILa
Ella Sorani 0.005517 %	66,150	0.005517 %	3 214 ILa
Avraham Molcho 0.000000 %	0	0.000000 %	- ILa

Name	Equities	%	Valuation
Morgan Stanley Capital Services LLC 0.3645 %	291,354	0.3645 %	217 350 ILa
Susquehanna Securities LLC 0.2563 %	204,914	0.2563 %	152 866 ILa
Values First Advisors, Inc. 0.2547 %	203,633	0.2547 %	151 910 ILa
LPL Financial LLC 0.1255 %	100,323	0.1255 %	74 841 ILa
Western International Securities, Inc. 0.1243 %	99,333	0.1243 %	74 102 ILa
PVG Asset Management Corp. 0.0774 %	61,840	0.0774 %	46 133 ILa
RBC Dominion Securities, Inc. 0.0681 %	54,471	0.0681 %	40 635 ILa
Geode Capital Management LLC 0.0500 %	39,993	0.0500 %	29 835 ILa
RATHBONES GROUP PLC 0.0498 %	39,820	0.0498 %	29 706 ILa
Geneos Wealth Management, Inc. 0.0482 %	38,500	0.0482 %	28 721 ILa

BioLineRx Ltd.

Modi'in Technology Park 2 HaMa'ayan Street

7177871, Modi'in

+972 8 642 9100

http://www.biolinerx.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BIOLINERX LTD.	-54.97%	55.75M
VERTEX PHARMACEUTICALS INCORPORATED	+16.93%	124B
REGENERON PHARMACEUTICALS, INC.	+17.01%	109B
BIONTECH SE	-7.23%	23.84B
ARGENX SE	+1.98%	22.42B
GENMAB A/S	-14.29%	17.5B
BEIGENE, LTD.	-6.79%	16.61B
WUXI APPTEC CO., LTD.	-37.63%	16.43B
NEUROCRINE BIOSCIENCES, INC.	+2.17%	13.4B
SAREPTA THERAPEUTICS, INC.	+24.42%	11.47B

Bio Therapeutic Drugs